Zofenopril reduced the ratio of left ventricular weight to body weight more effectively than hydralazine (2.4 vs 3.3 g/kg, P<0.005) in spontaneously hypertensive rats.
Does zofenopril or hydralazine improve pulsatile hemodynamics and regress left ventricular hypertrophy in spontaneously hypertensive rats?
In spontaneously hypertensive rats, zofenopril is more effective than hydralazine at regressing left ventricular hypertrophy due to a greater reduction in total left ventricular load and pulsatile load.
Absolute Event Rate: 2.4% vs 3.9%
p-value: p=<.005
BACKGROUND: Converting enzyme inhibitors are more effective than arteriolar vasodilators at regressing left ventricular hypertrophy in spontaneously hypertensive rats (SHR), possibly because of nonhemodynamic factors. However, the pulsatile component of hemodynamic load has not been evaluated in this model. METHODS AND RESULTS: We measured pulsatile hemodynamics in 18-month-old male SHR after 6 months of therapy with either zofenopril (Z), hydralazine (H), or water (W). Hydralazine and zofenopril reduced mean arterial pressure comparably (W, 106 +/- 23 versus H, 81 +/- 12 versus Z, 84 +/- 18 mm Hg, P = .002) yet had a differential effect on the ratio of left ventricular weight to body weight (W, 3.9 +/- 0.5 versus H, 3.3 +/- 0.4 versus Z, 2.4 +/- 0.2 g/kg, P < .005). Hydralazine-treated SHR had increased characteristic impedance (P = .0011) and a persistently low ratio of the reflected-wave transit time to left ventricular ejection time (P < .001), which contributed to early and late systolic loading, respectively, of the left ventricle. Consequently, only zofenopril-treated SHR had a significant reduction in left ventricular systolic force-time integral (P = .02), a measure of total ventricular load. There were no differences in systolic stress-time integral, suggesting that mass was appropriate to load when all elements of steady-flow and pulsatile load were considered. CONCLUSIONS: A blunted reduction in total left ventricular load, due to increased pulsatile load in SHR treated with hydralazine, provided a hemodynamic basis for the differential regression of hypertrophy in this model of genetic hypertension.
Mitchell et al. (1996) studied Hypertension (Spontaneously Hypertensive Rats). Zofenopril or Hydralazine vs. Water was evaluated on Ratio of left ventricular weight to body weight (p=<.005). Zofenopril reduced the ratio of left ventricular weight to body weight more effectively than hydralazine (2.4 vs 3.3 g/kg, P<0.005) in spontaneously hypertensive rats.